What is DSI?
Data Sciences International (DSI), a division of Harvard Bioscience, specializes in providing a comprehensive preclinical platform designed to assess physiological data from research animals. The company offers a suite of integrated solutions, including advanced telemetry systems, pulmonary solutions, sophisticated associated software platforms, and dedicated services. DSI's commitment to innovation in this critical research area positions it as a key enabler for scientific discovery and development in the life sciences.
How much funding has DSI raised?
DSI has raised a total of $12M across 1 funding round:
Series A
$12M
Series A (2002): $12M, investors not publicly disclosed
What's next for DSI?
The recent major strategic investment in DSI signals a strong confidence in the company's future trajectory and its capacity for continued growth and innovation. This capital infusion is expected to fuel further development of its preclinical assessment technologies, potentially expanding its market reach and enhancing its platform capabilities. DSI's focus on providing robust physiological data solutions for research animals positions it to capitalize on the increasing demand for precise and reliable preclinical insights, particularly within the enterprise-level research landscape.
See full DSI company page